Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience.
  • Home
  • About Us
    • Management Team
    • Board of Directors
  • Products In Development
    • Intermezzo®
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Key Ratios
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
    • Shareholder Tools
      • Shareholder Briefcase
      • Printed Materials
      • Email Alerts
    • Proxy Materials
  • Careers
  • Contact
 

News & Events

    Thursday, June 11, 2009

    Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R)

    Tuesday, June 9, 2009

    Transcept Pharmaceuticals Presents Data at SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies

    Thursday, May 28, 2009

    Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009

    Thursday, May 21, 2009

    Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association

    Wednesday, May 13, 2009

    Transcept Pharmaceuticals Reports First Quarter 2009 Financial Results

    Tuesday, May 5, 2009

    Transcept Pharmaceuticals to Report First Quarter 2009 Results

Transcept Stock Quote
Copyright © 2009  |  
Sitemap  |  Contact Us